156.00
156.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
CID-0-RAB Tablet is a combination of Rabeprazole Sodium 20 mg and Domperidone 30 mg, used to treat acid reflux, gastroesophageal reflux disease (GERD), and other digestive disorders associated with excessive stomach acid and delayed gastric emptying. Rabeprazole acts as a proton pump inhibitor (PPI), while Domperidone is a prokinetic agent that enhances gastrointestinal motility. Together, they offer fast and long-lasting relief from heartburn, bloating, indigestion, and nausea. Manufactured under stringent quality norms by BluepillExpress, CID-0-RAB ensures effective acid suppression and upper GI symptom management.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CID-0-RAB Tablet is a highly effective gastroprokinetic and acid suppression therapy that combines the benefits of Rabeprazole Sodium (20 mg) and Domperidone (30 mg). This dual-action medication is used in the treatment of gastric acid-related disorders, including GERD (Gastroesophageal Reflux Disease), peptic ulcers, acid reflux, indigestion, gastritis, functional dyspepsia, and nausea-vomiting associated with gastrointestinal dysfunction.
Rabeprazole Sodium is a proton pump inhibitor (PPI) that blocks the H+/K+ ATPase enzyme system in gastric parietal cells, effectively reducing the secretion of hydrochloric acid in the stomach. It provides long-lasting acid suppression, enabling ulcer healing and relief from symptoms like heartburn, acid regurgitation, and epigastric pain. Rabeprazole begins its action within one hour of administration and achieves maximum effect within 2–4 hours, with a prolonged duration of action.
Domperidone, on the other hand, is a dopamine D2 receptor antagonist that acts on the chemoreceptor trigger zone (CTZ) and enhances gastrointestinal motility by increasing the tone and amplitude of gastric contractions. It helps in the faster movement of food from the stomach to the intestine and prevents nausea and vomiting. It is particularly effective in managing gastroparesis, bloating, post-meal fullness, and nausea associated with acid disorders or medication use.
The synergistic combination of Rabeprazole and Domperidone in CID-0-RAB provides symptomatic relief from upper GI tract disorders, addresses the root cause (excess acid production), and improves gastric emptying. It is particularly helpful in patients who suffer from refractory GERD, non-ulcer dyspepsia, or acid reflux due to delayed gastric clearance.
CID-0-RAB is commonly prescribed for the following indications:
Gastroesophageal Reflux Disease (GERD)
Non-ulcer dyspepsia
Acid peptic disease
Zollinger-Ellison Syndrome
Gastritis with upper GI motility dysfunction
Functional dyspepsia
Chronic heartburn
Nausea and vomiting induced by medications or delayed gastric emptying
